Antisense oligonucleotides reduce synthesis of procollagen α1 (V) chain in human patellar tendon fibroblasts: Potential application in healing ligaments and tendons

Takatoshi Shimomura, Fengyan Jia, Christopher Niyibizi, Savio L.Y. Woo

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Many ligaments and tendons will heal after injury. However, they heal with poor mechanical properties when compared with the native tissue and show no improvement of these properties with time. Although the mechanisms that lead to this process are poorly understood, the presence of uniformly smaller collagen fibrils is believed to play a major role. Quantitatively minor when compared with type I collagen, type V collagen was found to be significantly elevated in healing medial collateral ligament of the rabbit knee. Previous studies have shown that type V collagen plays a role in regulating the diameter of type I collagen fibrils and reducing its level may lead to the formation of larger collagen fibrils in healing ligaments. Hence, type V collagen antisense gene therapy may be an approach to obtain this goal. In this study, our objective was to find specific antisense oligonucleotide sequences for type V procollagen α1 chain to elucidate the feasibility of type V collagen antisense gene therapy in ligaments or tendons. We hypothesized that antisense oligonucleotides that selectively target the type V procollagen α1 chain mRNA could partially reduce the synthesis of type V procollagen α1 chain in human tendon fibroblasts. Western blotting analysis showed that antisense oligonucleotides (AS-V1 and AS-V2) significantly reduced synthesis of type V procollagen α1 chain. In addition, reverse transcription polymerase chain reaction revealed that both antisense oligonucleotides partially reduced type V procollagen α1 chain mRNA expression. This experiment identified two sequences within the type V procollagen coding region that are susceptible to antisense suppression, and thus provide the basis to explore the effects of antisense oligonucleotides on type V collagen synthesis, collagen fibril diameter, and mechanical properties of healing tendons and ligaments.

Original languageEnglish (US)
Pages (from-to)167-172
Number of pages6
JournalConnective Tissue Research
Volume44
Issue number3-4
StatePublished - Nov 3 2003

Fingerprint

Collagen Type V
Procollagen
Patellar Ligament
Antisense Oligonucleotides
Ligaments
Tendons
Fibroblasts
Collagen Type I
Collagen
Genetic Therapy
Knee Medial Collateral Ligament
Gene therapy
Messenger RNA
Reverse Transcription
Western Blotting
Mechanical properties
Rabbits
Polymerase Chain Reaction
Polymerase chain reaction
Transcription

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Biochemistry
  • Orthopedics and Sports Medicine
  • Molecular Biology
  • Cell Biology

Cite this

@article{da5f285182824ecda9ba24b95950552d,
title = "Antisense oligonucleotides reduce synthesis of procollagen α1 (V) chain in human patellar tendon fibroblasts: Potential application in healing ligaments and tendons",
abstract = "Many ligaments and tendons will heal after injury. However, they heal with poor mechanical properties when compared with the native tissue and show no improvement of these properties with time. Although the mechanisms that lead to this process are poorly understood, the presence of uniformly smaller collagen fibrils is believed to play a major role. Quantitatively minor when compared with type I collagen, type V collagen was found to be significantly elevated in healing medial collateral ligament of the rabbit knee. Previous studies have shown that type V collagen plays a role in regulating the diameter of type I collagen fibrils and reducing its level may lead to the formation of larger collagen fibrils in healing ligaments. Hence, type V collagen antisense gene therapy may be an approach to obtain this goal. In this study, our objective was to find specific antisense oligonucleotide sequences for type V procollagen α1 chain to elucidate the feasibility of type V collagen antisense gene therapy in ligaments or tendons. We hypothesized that antisense oligonucleotides that selectively target the type V procollagen α1 chain mRNA could partially reduce the synthesis of type V procollagen α1 chain in human tendon fibroblasts. Western blotting analysis showed that antisense oligonucleotides (AS-V1 and AS-V2) significantly reduced synthesis of type V procollagen α1 chain. In addition, reverse transcription polymerase chain reaction revealed that both antisense oligonucleotides partially reduced type V procollagen α1 chain mRNA expression. This experiment identified two sequences within the type V procollagen coding region that are susceptible to antisense suppression, and thus provide the basis to explore the effects of antisense oligonucleotides on type V collagen synthesis, collagen fibril diameter, and mechanical properties of healing tendons and ligaments.",
author = "Takatoshi Shimomura and Fengyan Jia and Christopher Niyibizi and Woo, {Savio L.Y.}",
year = "2003",
month = "11",
day = "3",
language = "English (US)",
volume = "44",
pages = "167--172",
journal = "Connective Tissue Research",
issn = "0300-8207",
publisher = "Informa Healthcare",
number = "3-4",

}

Antisense oligonucleotides reduce synthesis of procollagen α1 (V) chain in human patellar tendon fibroblasts : Potential application in healing ligaments and tendons. / Shimomura, Takatoshi; Jia, Fengyan; Niyibizi, Christopher; Woo, Savio L.Y.

In: Connective Tissue Research, Vol. 44, No. 3-4, 03.11.2003, p. 167-172.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antisense oligonucleotides reduce synthesis of procollagen α1 (V) chain in human patellar tendon fibroblasts

T2 - Potential application in healing ligaments and tendons

AU - Shimomura, Takatoshi

AU - Jia, Fengyan

AU - Niyibizi, Christopher

AU - Woo, Savio L.Y.

PY - 2003/11/3

Y1 - 2003/11/3

N2 - Many ligaments and tendons will heal after injury. However, they heal with poor mechanical properties when compared with the native tissue and show no improvement of these properties with time. Although the mechanisms that lead to this process are poorly understood, the presence of uniformly smaller collagen fibrils is believed to play a major role. Quantitatively minor when compared with type I collagen, type V collagen was found to be significantly elevated in healing medial collateral ligament of the rabbit knee. Previous studies have shown that type V collagen plays a role in regulating the diameter of type I collagen fibrils and reducing its level may lead to the formation of larger collagen fibrils in healing ligaments. Hence, type V collagen antisense gene therapy may be an approach to obtain this goal. In this study, our objective was to find specific antisense oligonucleotide sequences for type V procollagen α1 chain to elucidate the feasibility of type V collagen antisense gene therapy in ligaments or tendons. We hypothesized that antisense oligonucleotides that selectively target the type V procollagen α1 chain mRNA could partially reduce the synthesis of type V procollagen α1 chain in human tendon fibroblasts. Western blotting analysis showed that antisense oligonucleotides (AS-V1 and AS-V2) significantly reduced synthesis of type V procollagen α1 chain. In addition, reverse transcription polymerase chain reaction revealed that both antisense oligonucleotides partially reduced type V procollagen α1 chain mRNA expression. This experiment identified two sequences within the type V procollagen coding region that are susceptible to antisense suppression, and thus provide the basis to explore the effects of antisense oligonucleotides on type V collagen synthesis, collagen fibril diameter, and mechanical properties of healing tendons and ligaments.

AB - Many ligaments and tendons will heal after injury. However, they heal with poor mechanical properties when compared with the native tissue and show no improvement of these properties with time. Although the mechanisms that lead to this process are poorly understood, the presence of uniformly smaller collagen fibrils is believed to play a major role. Quantitatively minor when compared with type I collagen, type V collagen was found to be significantly elevated in healing medial collateral ligament of the rabbit knee. Previous studies have shown that type V collagen plays a role in regulating the diameter of type I collagen fibrils and reducing its level may lead to the formation of larger collagen fibrils in healing ligaments. Hence, type V collagen antisense gene therapy may be an approach to obtain this goal. In this study, our objective was to find specific antisense oligonucleotide sequences for type V procollagen α1 chain to elucidate the feasibility of type V collagen antisense gene therapy in ligaments or tendons. We hypothesized that antisense oligonucleotides that selectively target the type V procollagen α1 chain mRNA could partially reduce the synthesis of type V procollagen α1 chain in human tendon fibroblasts. Western blotting analysis showed that antisense oligonucleotides (AS-V1 and AS-V2) significantly reduced synthesis of type V procollagen α1 chain. In addition, reverse transcription polymerase chain reaction revealed that both antisense oligonucleotides partially reduced type V procollagen α1 chain mRNA expression. This experiment identified two sequences within the type V procollagen coding region that are susceptible to antisense suppression, and thus provide the basis to explore the effects of antisense oligonucleotides on type V collagen synthesis, collagen fibril diameter, and mechanical properties of healing tendons and ligaments.

UR - http://www.scopus.com/inward/record.url?scp=0142217351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142217351&partnerID=8YFLogxK

M3 - Article

C2 - 14504037

AN - SCOPUS:0142217351

VL - 44

SP - 167

EP - 172

JO - Connective Tissue Research

JF - Connective Tissue Research

SN - 0300-8207

IS - 3-4

ER -